The document is a Covid-19 test report for a patient named Abu Sayed Ahmed. It indicates that a sample was collected from him on February 20, 2022 and tested at the Dispur Clinical Laboratory in Guwahati, India. The test result was negative for SARS-CoV2. Additional information provided includes the patient's age, gender, contact number, and test details like specimen type, test type, and result reporting date and time.
The document is a Covid-19 test report for a patient named Abu Sayed Ahmed. It indicates that a sample was collected from him on February 20, 2022 and tested at the Dispur Clinical Laboratory in Guwahati, India. The test result was negative for SARS-CoV2. Additional information provided includes the patient's age, gender, contact number, and test details like specimen type, test type, and result reporting date and time.
The document is a Covid-19 test report for a patient named Abu Sayed Ahmed. It indicates that a sample was collected from him on February 20, 2022 and tested at the Dispur Clinical Laboratory in Guwahati, India. The test result was negative for SARS-CoV2. Additional information provided includes the patient's age, gender, contact number, and test details like specimen type, test type, and result reporting date and time.
The document is a Covid-19 test report for a patient named Abu Sayed Ahmed. It indicates that a sample was collected from him on February 20, 2022 and tested at the Dispur Clinical Laboratory in Guwahati, India. The test result was negative for SARS-CoV2. Additional information provided includes the patient's age, gender, contact number, and test details like specimen type, test type, and result reporting date and time.
Date Time of Sample 20-02-2022 15:37:17 Date Time of Sample 20-02-2022 15:45:12 Collection: Received at Lab:
Date Time of Sample 20-02-2022 15:50:12 Date Time of Result 20-02-2022 17:24:21 Testing: Reported:
Checked and Approved by:
----------------------------
Scan for e-Verify
Note: The results relate only to the specimens tested and should be correlated with clinical findings. Interpretation guidance:- 1. Testing of referred clinical specimens was considered on the basis of request / referral received from / through State Surveillance Officer (SSO) of concerned State Integrated Disease Surveillance Programme (IDSP)/ any other health care facility affirming requirements of the case definition/s. 2. A single negative test result, particularly if this is from an upper respiratory tract specimen, does not exclude infection* 3. A positive test result is only tentative, and will be reconfirmed by retesting 4. Repeat sampling and testing of lower respiratory specimen is strongly recommended in severe or progressive disease. The repeat specimens may be considered after a gap of 2 – 4 days after the collection of the first specimen for additional testing if required. * 5. A positive alternate pathogen does not necessarily rule out either, as little is yet known about the role of coinfections. 6. Please note that these results are not to be used for any thesis or presentations or for Publication in any Journal without the prior permission of the Director General, ICMR
